Evaluate Ltd. Appoints Deborah Kobewka as Chief Executive Officer

LONDON & BOSTON & TOKYO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/biopharma?src=hash" target="_blank"gt;#biopharmalt;/agt;–Evaluate Ltd., the leading provider of commercial data to the life
sciences industry, is pleased to announce the appointment of Deborah
Kobewka as Chief Executive Officer, effective immediately. Deborah
succeeds Alex Karle, who joined Evaluate in 2012 as Chief Operating
Officer before assuming the role of CEO in 2014.

Deborah brings to Evaluate over 30 years of expertise in the global
pharmaceutical, healthcare and information sectors. With her successful
track record of driving commercial expansion, she is well positioned to
accelerate the company’s current growth trajectory.

Deborah joins Evaluate from the Department for International Trade in
the UK government where she served as Managing Director of Healthcare
UK, Lifesciences and Bio-economy. Prior to that, she held senior
corporate and operational roles at both private and government
organisations in the UK, Europe and Asia, including 24 years at IMS
Health (now IQVIA).

“Evaluate has an impressive history of pioneering solutions for life
science decision makers,” said Deborah Kobewka. “I’m honoured to be
leading the organisation as we embark on our next phase of innovation,
and look forward to delivering new resources that improve results for
both our clients and the wider industry.”

“We’re delighted to welcome Deborah to Evaluate,” said Jonathan de Pass,
Chairman at Evaluate. “We’ve experienced impressive growth over the last
several years and Deborah is the perfect leader to build on this
success. Deborah’s deep knowledge of our sector and clients will be
invaluable in driving our strategy as Evaluate continues to grow and
evolve.”

Jonathan continued: “On behalf of Evaluate’s Board of Directors, I would
also like to thank Alex Karle for his enormous contribution leading the
company over the last six and a half years. Our business became
immeasurably stronger throughout his tenure, and we wish him every
success in the next phase of his career.”

About Evaluate Ltd.

Evaluate provides trusted commercial intelligence for the pharmaceutical
and medical device industries. Our EvaluatePharma® online subscription
services provide a seamless view of the past, present and future of the
global pharmaceutical market in a single, standardised platform.

Vantage – our award-winning, independent editorial team – provides
thought-provoking news and insights into the current and future
developments in the industry.

Evaluate has been a partner to industry-leading organisations for over
20 years. For more information on how we give our clients the time and
understanding to drive better decisions, visit www.evaluate.com.

Follow us on Twitter: @EvaluatePharma, @EvaluateMedtech, @Vantageanalysis

Contacts

Evaluate Ltd.
Jennifer Dinkel
+1 617-936-7783
[email protected]